Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BCC 2025 | Unmet needs in younger patients with breast cancer

Cynthia Villarreal-Garza • 13 Mar 2025
BCC 2025
Breast Cancer

Cynthia Villarreal-Garza, MD, DSc, TecSalud, Monterrey, Mexico, discusses the unmet needs of younger patients with breast cancer, including treatment-induced menopause, sexual dysfunction, bone health issues, and psychological concerns. To address these needs, a multidisciplinary team approach, patient monitoring, and access to web-based interventions, educational resources, and peer support groups are all needed. This interview took place at the 2025 St. Gallen International Breast Cancer Consensus Meeting in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Cynthia Villarreal-Garza

Survivorship challenges in young patients with breast cancer
0:56
Survivorship challenges in young patients with breast cancer
Cynthia Villarreal-Garza • 13 Mar 2025
Evaluating sexual dysfunction in young women with breast cancer
0:55
Evaluating sexual dysfunction in young women with breast cancer
Cynthia Villarreal-Garza • 13 Mar 2025
Improving access to endocrine therapies in Mexico
1:00
Improving access to endocrine therapies in Mexico
Cynthia Villarreal-Garza • 25 Mar 2021
Prescribing practices of endocrine therapy for premenopausal breast cancer patients in Mexico
4:05
Prescribing practices of endocrine therapy for premenopausal breast cancer patients in Mexico
Cynthia Villarreal-Garza • 25 Mar 2021

Related Videos

Stress and depression linked to tumor transcriptional signatures in breast cancer
1:21
Stress and depression linked to tumor transcriptional signatures in breast cancer
Shipra Gandhi • 31 May 2026
DESTINY-Breast07: final analysis of T-DXd and durvalumab in 1L HER2+ breast cancer
1:13
DESTINY-Breast07: final analysis of T-DXd and durvalumab in 1L HER2+ breast cancer
Shipra Gandhi • 31 May 2026
TBCRC-053: preoperative radiotherapy & pembrolizumab in node-positive TNBC
1:34
TBCRC-053: preoperative radiotherapy & pembrolizumab in node-positive TNBC
Shipra Gandhi • 1 Jun 2026
HELEN-Trio 011: camrelizumab plus chemotherapy as neoadjuvant therapy in TNBC
0:49
HELEN-Trio 011: camrelizumab plus chemotherapy as neoadjuvant therapy in TNBC
Shipra Gandhi • 1 Jun 2026
The content of VJOncology is intended for healthcare professionals